Psychological and Quality of Life Impact of Brain in Hand
BraininHand
1 other identifier
observational
101
1 country
1
Brief Summary
A prospective cohort mixed study using both qualitative and quantitative elements. The quantitative component will involve tracking outcomes at baseline and at twelve weeks, using Health of the Nation Outcome Scale for People with a Learning Disability (for quality of life) and Hospital Anxiety and Depression Rating Scale (for anxiety and depression). The qualitative study will involve semi structured interviews with end users to understand usage and acceptability of Brain in Hand app with the added impact of the pandemic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedFirst Submitted
Initial submission to the registry
June 22, 2022
CompletedFirst Posted
Study publicly available on registry
July 21, 2022
CompletedJuly 21, 2022
June 1, 2022
5 months
June 22, 2022
July 20, 2022
Conditions
Outcome Measures
Primary Outcomes (11)
What is the impact of BiH on quality of life over a three-month period?
The Health of the Nation Outcome Scales for People with Learning Disabilities is measured on a five-point scale (0-4) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared
3 months
What is the impact of BiH on the participant's mental health?
Hospital Anxiety and Depression Scale is measured on a four-point scale (0-3) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared
3 months
Level of acceptability (drop-out rates)
Drop out rates will be recorded
3 months
Discover the participant's experience of using BiH App to measure outcomes of reliance on their care support
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
Understand how BiH impacts on coping skills
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
To gain understanding of how BIH has impacted on the autistic person's ability to manage challenging social situations
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
Does BiH App help autistic people feel safe?
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
Does the BiH help autistic people feel more independent?
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
Can access 24/7 telephone support help autistic people feel self-empowered to manage their anxiety?
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
To gain an understanding of how BiH Traffic Light system helps a person manage their anxiety, independence and support their coping skills
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
Does the participant believe remote support has improved their access to healthcare during the pandemic?
Short semi structured interviews with ten end users to understand usage and acceptability
3 months
Eligibility Criteria
Members of the participant's existing clinical care team will access their patient records and their autism waiting list to identify potential participants for the study with the participation criteria followed without deviation.
You may qualify if:
- All who have been diagnosed with Autism Spectrum Disorder (ASD) as per DSM-5 criteria level (1) or post screening by health professional such as a GP and on the confirmatory diagnostic pathway.
- Age ranges from 19 to 80.
- Participant has been screened by the Columbia Suicide Rating Scale as not having risk concerns of suicide.
- Access to smart devices with compatibility to running BiH. The Participant will require a Smart Phone and either a Laptop / Tablet / Note Book.
- Has capacity to give informed consent and can give informed consent.
- They can understand the BiH information.
You may not qualify if:
- Any acute or chronic condition, particularly neurodevelopmental conditions such as significant intellectual disability, Level 2/3 DSM V ASD.
- Diagnosed con-current psychological comorbidity (psychosis, severe depression etc.) that would limit the ability of the participant to take part in the study.
- Anyone who declines to give consent or are unable to give informed consent. 5. Anyone who has been screened positive with the (C-SSRS) suicide risk scale.
- \. Not willing to engage with smart device/internet. 7. Insufficient English language to understand and complete questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cornwall Partnership NHS Foundation Trustlead
- braininhand.co.ukcollaborator
Study Sites (1)
Cornwall Partnership NHS Foundation Trust
Bodmin, Cornwall, PL31 2QN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2022
First Posted
July 21, 2022
Study Start
July 30, 2021
Primary Completion
December 31, 2021
Study Completion
March 31, 2022
Last Updated
July 21, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share